Internal Medicine, Endocrinology, Diabetes, & Metabolism · Winter Haven, FL
NPI
1710915954
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
199 Avenue B NW
Winter Haven, FL, 33881
Phone (863) 293-1191
Groups this clinician bills Medicare through
Medicare paid, 2024
$181K
16,636 services
Medicare patients, 2024
563
Average age 75
Drug cost, 2024
$2.1M
4,246 prescriptions
Company payments, 2025
$1,513
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ganesh K Nair was code 99214 (office e&m - established), 1,074 times for 502 patients. In total Ganesh K Nair billed 16,636 services in 85 codes, and Medicare paid $181K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,074 | 502 | $88.10 | $95K |
| 36415 Venipuncture Blood Collection | Office | 570 | 349 | $8.65 | $4,931 |
| 84439 Clinical Chemistry | Office | 451 | 280 | $8.84 | $3,987 |
| 84443 Clinical Chemistry | Office | 441 | 294 | $16.46 | $7,259 |
| 80048 Clinical Chemistry | Office | 260 | 166 | $8.29 | $2,155 |
| 95251 Test - Miscellaneous | Office | 247 | 102 | $26.02 | $6,426 |
| 83036 Blood Count | Office | 175 | 109 | $9.52 | $1,666 |
| 76536 Ultrasound - Nonspecific | Office | 125 | 118 | $76.97 | $9,621 |
| 84460 Clinical Chemistry | Office | 120 | 80 | $5.19 | $623 |
| 83970 Clinical Chemistry | Office | 120 | 71 | $40.45 | $4,854 |
| 84450 Clinical Chemistry | Office | 120 | 80 | $5.08 | $610 |
| 82306 Clinical Chemistry | Office | 80 | 58 | $29.01 | $2,321 |
| 96372 Injection Administration | Office | 74 | 14 | $9.73 | $720 |
| 82570 Clinical Chemistry | Office | 69 | 53 | $5.08 | $351 |
| 84100 Clinical Chemistry | Office | 62 | 44 | $4.65 | $288 |
By year: 2022 $179K for 17,207 services; 2023 $166K for 19,242 services; 2024 $181K for 16,636 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 570 | 349 | $8.65 | $4,931 |
| 84439 Clinical Chemistry | 451 | 280 | $8.84 | $3,987 |
| 84443 Clinical Chemistry | 441 | 294 | $16.46 | $7,259 |
| 80048 Clinical Chemistry | 260 | 166 | $8.29 | $2,155 |
| 83036 Blood Count | 175 | 109 | $9.52 | $1,666 |
| 83970 Clinical Chemistry | 120 | 71 | $40.45 | $4,854 |
| 84450 Clinical Chemistry | 120 | 80 | $5.08 | $610 |
| 84460 Clinical Chemistry | 120 | 80 | $5.19 | $623 |
| 82306 Clinical Chemistry | 80 | 58 | $29.01 | $2,321 |
| 82570 Clinical Chemistry | 69 | 53 | $5.08 | $351 |
Medicare prescription drug claims, 2024
In 2024, the drug Ganesh K Nair prescribed most often to Medicare patients was Levothyroxine Sodium, with 753 prescriptions and refills. In total Ganesh K Nair wrote 4,246 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 753 | 1,940 | 249 | $6,730 |
| Ozempic Semaglutide | 224 | 420 | 79 | $404K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 182 | 502 | 75 | $30K |
| Mounjaro Tirzepatide | 168 | 230 | 37 | $244K |
| Synthroid Levothyroxine Sodium | 167 | 425 | 56 | $16K |
| Metformin Hcl Generic | 144 | 398 | 54 | $1,205 |
| Methimazole Generic | 135 | 341 | 52 | $1,153 |
| Trulicity Dulaglutide | 127 | 240 | 49 | $237K |
| Novolog Flexpen Insulin Aspart | 119 | 270 | 61 | $52K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 101 | 272 | 48 | $16K |
| Metformin Hcl Er Metformin Hcl | 101 | 258 | 36 | $970 |
| Humalog Kwikpen U-100 Insulin Lispro | 100 | 245 | 43 | $55K |
| Jardiance Empagliflozin | 92 | 188 | 35 | $109K |
| Glimepiride Generic | 87 | 231 | 32 | $810 |
| Glipizide Generic | 74 | 194 | 31 | $647 |
Brand drugs: 2,699 claims; generic drugs: 1,224 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ganesh K Nair $1,513 ($1,513 in general payments such as food, travel and fees) from 23 companies. The largest payer was Boston Scientific Corporation with $162.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 1 | $162 |
| Novo Nordisk Inc NVO | 12 | $157 |
| Amneal Pharmaceuticals LLC AMRX | 8 | $143 |
| Ascendis Pharma Endocrinology Inc ASND | 5 | $120 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $101 |
| Amgen Inc. AMGN | 5 | $100 |
| Corcept Therapeutics CORT | 4 | $94.53 |
| Insulet Corporation PODD | 3 | $85.27 |
| Lilly USA, LLC LLY | 3 | $78.22 |
| Dexcom, Inc. DXCM | 4 | $74.82 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.